A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Clinical Activity of EQ001 in Subjects with Moderate-To-Severe Uncontrolled Asthma

Project: Research

Project Description

NMA HREC Reference Number: HREC/52396/MH-2019
NMA SSA Reference Number: SSA/52396/MonH-2019-178141(v1
Monash Health Ref Number: RES-19-0000-473X
StatusNot started

Keywords

  • phase 1 study
  • treatment efficacy
  • asthma
  • clinical trial